Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SP3
|
ENSG00000172845.9 | Sp3 transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SP3 | hg19_v2_chr2_-_174828892_174828972 | 0.21 | 2.7e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chrY_+_22737678 | 4.95 |
ENST00000382772.3
|
EIF1AY
|
eukaryotic translation initiation factor 1A, Y-linked |
chr10_+_135192695 | 4.88 |
ENST00000368539.4
ENST00000278060.5 ENST00000357296.3 |
PAOX
|
polyamine oxidase (exo-N4-amino) |
chr10_+_11784360 | 4.51 |
ENST00000379215.4
ENST00000420401.1 |
ECHDC3
|
enoyl CoA hydratase domain containing 3 |
chr10_+_135192782 | 4.33 |
ENST00000480071.2
|
PAOX
|
polyamine oxidase (exo-N4-amino) |
chrY_+_22737604 | 3.77 |
ENST00000361365.2
|
EIF1AY
|
eukaryotic translation initiation factor 1A, Y-linked |
chr2_+_95691417 | 3.75 |
ENST00000309988.4
|
MAL
|
mal, T-cell differentiation protein |
chrX_+_30671476 | 3.63 |
ENST00000378946.3
ENST00000378943.3 ENST00000378945.3 ENST00000427190.1 ENST00000378941.3 |
GK
|
glycerol kinase |
chr1_+_211432775 | 3.53 |
ENST00000419091.2
|
RCOR3
|
REST corepressor 3 |
chr2_+_95691445 | 3.32 |
ENST00000353004.3
ENST00000354078.3 ENST00000349807.3 |
MAL
|
mal, T-cell differentiation protein |
chr17_-_76183111 | 3.29 |
ENST00000405273.1
ENST00000590862.1 ENST00000590430.1 ENST00000586613.1 |
TK1
|
thymidine kinase 1, soluble |
chr16_-_87903079 | 3.26 |
ENST00000261622.4
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
chr3_-_50340996 | 3.08 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
chr12_-_95044309 | 3.03 |
ENST00000261226.4
|
TMCC3
|
transmembrane and coiled-coil domain family 3 |
chr11_-_45687128 | 2.97 |
ENST00000308064.2
|
CHST1
|
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
chr19_-_14201507 | 2.92 |
ENST00000533683.2
|
SAMD1
|
sterile alpha motif domain containing 1 |
chr6_-_4135693 | 2.86 |
ENST00000495548.1
ENST00000380125.2 ENST00000465828.1 |
ECI2
|
enoyl-CoA delta isomerase 2 |
chr11_-_2160611 | 2.81 |
ENST00000416167.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr14_+_105941118 | 2.78 |
ENST00000550577.1
ENST00000538259.2 |
CRIP2
|
cysteine-rich protein 2 |
chr6_-_4135825 | 2.70 |
ENST00000380118.3
ENST00000413766.2 ENST00000361538.2 |
ECI2
|
enoyl-CoA delta isomerase 2 |
chr2_+_172378757 | 2.70 |
ENST00000409484.1
ENST00000321348.4 ENST00000375252.3 |
CYBRD1
|
cytochrome b reductase 1 |
chr2_-_241396131 | 2.65 |
ENST00000404327.3
|
AC110619.2
|
Uncharacterized protein |
chr11_-_2160180 | 2.65 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chrX_+_38420623 | 2.63 |
ENST00000378482.2
|
TSPAN7
|
tetraspanin 7 |
chrY_+_15016725 | 2.62 |
ENST00000336079.3
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked |
chr21_-_44496441 | 2.61 |
ENST00000359624.3
ENST00000352178.5 |
CBS
|
cystathionine-beta-synthase |
chr21_-_44495919 | 2.61 |
ENST00000398158.1
|
CBS
|
cystathionine-beta-synthase |
chr8_+_124428959 | 2.57 |
ENST00000287387.2
ENST00000523984.1 |
WDYHV1
|
WDYHV motif containing 1 |
chr4_-_819880 | 2.55 |
ENST00000505203.1
|
CPLX1
|
complexin 1 |
chr3_-_53290016 | 2.46 |
ENST00000423525.2
ENST00000423516.1 ENST00000296289.6 ENST00000462138.1 |
TKT
|
transketolase |
chr11_+_45944190 | 2.45 |
ENST00000401752.1
ENST00000389968.3 ENST00000325468.5 ENST00000536139.1 |
GYLTL1B
|
glycosyltransferase-like 1B |
chr12_+_50355647 | 2.44 |
ENST00000293599.6
|
AQP5
|
aquaporin 5 |
chr12_-_51785182 | 2.44 |
ENST00000356317.3
ENST00000603188.1 ENST00000604847.1 ENST00000604506.1 |
GALNT6
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) |
chr22_-_37915247 | 2.42 |
ENST00000251973.5
|
CARD10
|
caspase recruitment domain family, member 10 |
chr11_-_119187826 | 2.42 |
ENST00000264036.4
|
MCAM
|
melanoma cell adhesion molecule |
chr4_-_819901 | 2.40 |
ENST00000304062.6
|
CPLX1
|
complexin 1 |
chr22_+_42949925 | 2.37 |
ENST00000327678.5
ENST00000340239.4 ENST00000407614.4 ENST00000335879.5 |
SERHL2
|
serine hydrolase-like 2 |
chrX_+_38420783 | 2.36 |
ENST00000422612.2
ENST00000286824.6 ENST00000545599.1 |
TSPAN7
|
tetraspanin 7 |
chr18_+_11981547 | 2.34 |
ENST00000588927.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
chrX_-_134232630 | 2.32 |
ENST00000535837.1
ENST00000433425.2 |
LINC00087
|
long intergenic non-protein coding RNA 87 |
chr18_+_11981427 | 2.30 |
ENST00000269159.3
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
chr7_-_75368248 | 2.25 |
ENST00000434438.2
ENST00000336926.6 |
HIP1
|
huntingtin interacting protein 1 |
chr14_+_94640633 | 2.21 |
ENST00000304338.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
chr2_-_160761179 | 2.18 |
ENST00000554112.1
ENST00000553424.1 ENST00000263636.4 ENST00000504764.1 ENST00000505052.1 |
LY75
LY75-CD302
|
lymphocyte antigen 75 LY75-CD302 readthrough |
chr5_+_612387 | 2.17 |
ENST00000264935.5
ENST00000444221.1 |
CEP72
|
centrosomal protein 72kDa |
chr2_+_85811525 | 2.15 |
ENST00000306384.4
|
VAMP5
|
vesicle-associated membrane protein 5 |
chr5_-_60140009 | 2.15 |
ENST00000505959.1
|
ELOVL7
|
ELOVL fatty acid elongase 7 |
chr21_-_44495964 | 2.14 |
ENST00000398168.1
ENST00000398165.3 |
CBS
|
cystathionine-beta-synthase |
chr18_+_11981014 | 2.13 |
ENST00000589238.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
chr7_-_148580563 | 2.12 |
ENST00000476773.1
|
EZH2
|
enhancer of zeste homolog 2 (Drosophila) |
chr11_-_2158507 | 2.10 |
ENST00000381392.1
ENST00000381395.1 ENST00000418738.2 |
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr14_+_100070869 | 2.09 |
ENST00000502101.2
|
RP11-543C4.1
|
RP11-543C4.1 |
chr12_-_120315074 | 2.08 |
ENST00000261833.7
ENST00000392521.2 |
CIT
|
citron (rho-interacting, serine/threonine kinase 21) |
chr5_-_9546180 | 2.08 |
ENST00000382496.5
|
SEMA5A
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
chr2_-_197036289 | 2.07 |
ENST00000263955.4
|
STK17B
|
serine/threonine kinase 17b |
chr14_-_23834411 | 2.07 |
ENST00000429593.2
|
EFS
|
embryonal Fyn-associated substrate |
chr13_-_20806440 | 2.05 |
ENST00000400066.3
ENST00000400065.3 ENST00000356192.6 |
GJB6
|
gap junction protein, beta 6, 30kDa |
chr7_-_143059780 | 2.04 |
ENST00000409578.1
ENST00000409346.1 |
FAM131B
|
family with sequence similarity 131, member B |
chr16_-_90085824 | 2.04 |
ENST00000002501.6
|
DBNDD1
|
dysbindin (dystrobrevin binding protein 1) domain containing 1 |
chr10_-_135150367 | 2.04 |
ENST00000368555.3
ENST00000252939.4 ENST00000368558.1 ENST00000368556.2 |
CALY
|
calcyon neuron-specific vesicular protein |
chr3_-_128840604 | 2.03 |
ENST00000476465.1
ENST00000315150.5 ENST00000393304.1 ENST00000393308.1 ENST00000393307.1 ENST00000393305.1 |
RAB43
|
RAB43, member RAS oncogene family |
chr20_+_37554955 | 2.03 |
ENST00000217429.4
|
FAM83D
|
family with sequence similarity 83, member D |
chr12_-_125348329 | 2.02 |
ENST00000546215.1
ENST00000415380.2 ENST00000261693.6 ENST00000376788.1 ENST00000545493.1 |
SCARB1
|
scavenger receptor class B, member 1 |
chr7_-_150780487 | 2.02 |
ENST00000482202.1
|
TMUB1
|
transmembrane and ubiquitin-like domain containing 1 |
chr6_+_80714318 | 2.02 |
ENST00000369798.2
|
TTK
|
TTK protein kinase |
chr19_-_55658687 | 2.01 |
ENST00000593046.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr12_-_125348448 | 1.97 |
ENST00000339570.5
|
SCARB1
|
scavenger receptor class B, member 1 |
chr1_+_43824577 | 1.95 |
ENST00000310955.6
|
CDC20
|
cell division cycle 20 |
chr8_-_124428569 | 1.94 |
ENST00000521903.1
|
ATAD2
|
ATPase family, AAA domain containing 2 |
chr19_-_10679644 | 1.94 |
ENST00000393599.2
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
chr14_+_21538517 | 1.94 |
ENST00000298693.3
|
ARHGEF40
|
Rho guanine nucleotide exchange factor (GEF) 40 |
chr11_-_19263145 | 1.94 |
ENST00000532666.1
ENST00000527884.1 |
E2F8
|
E2F transcription factor 8 |
chr10_-_25241499 | 1.93 |
ENST00000376378.1
ENST00000376376.3 ENST00000320152.6 |
PRTFDC1
|
phosphoribosyl transferase domain containing 1 |
chr10_-_103535657 | 1.92 |
ENST00000344255.3
ENST00000320185.2 ENST00000346714.3 ENST00000347978.2 |
FGF8
|
fibroblast growth factor 8 (androgen-induced) |
chr2_-_72375167 | 1.91 |
ENST00000001146.2
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1 |
chr6_-_33714667 | 1.88 |
ENST00000293756.4
|
IP6K3
|
inositol hexakisphosphate kinase 3 |
chr19_-_14201776 | 1.88 |
ENST00000269724.5
|
SAMD1
|
sterile alpha motif domain containing 1 |
chr10_+_35415851 | 1.87 |
ENST00000374726.3
|
CREM
|
cAMP responsive element modulator |
chr19_-_10679697 | 1.87 |
ENST00000335766.2
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
chr15_-_34659349 | 1.87 |
ENST00000314891.6
|
LPCAT4
|
lysophosphatidylcholine acyltransferase 4 |
chr19_-_2015699 | 1.86 |
ENST00000255608.4
|
BTBD2
|
BTB (POZ) domain containing 2 |
chr4_+_1873100 | 1.85 |
ENST00000508803.1
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1 |
chr8_+_124429006 | 1.85 |
ENST00000522194.1
ENST00000523356.1 |
WDYHV1
|
WDYHV motif containing 1 |
chr19_-_15344243 | 1.83 |
ENST00000602233.1
|
EPHX3
|
epoxide hydrolase 3 |
chr10_+_94833642 | 1.83 |
ENST00000224356.4
ENST00000394139.1 |
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1 |
chr2_-_241396106 | 1.83 |
ENST00000404891.1
|
AC110619.2
|
Uncharacterized protein |
chr10_-_15210615 | 1.82 |
ENST00000378150.1
|
NMT2
|
N-myristoyltransferase 2 |
chr19_+_11201275 | 1.81 |
ENST00000252444.5
|
LDLR
|
low density lipoprotein receptor |
chr9_+_138606400 | 1.80 |
ENST00000486577.2
|
KCNT1
|
potassium channel, subfamily T, member 1 |
chr13_+_110959598 | 1.80 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
chr9_-_136223324 | 1.80 |
ENST00000371974.3
|
SURF1
|
surfeit 1 |
chr9_+_139847347 | 1.80 |
ENST00000371632.3
|
LCN12
|
lipocalin 12 |
chr8_+_86376081 | 1.79 |
ENST00000285379.5
|
CA2
|
carbonic anhydrase II |
chr16_-_89787360 | 1.78 |
ENST00000389386.3
|
VPS9D1
|
VPS9 domain containing 1 |
chr18_+_77155856 | 1.78 |
ENST00000253506.5
ENST00000591814.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr7_+_100797726 | 1.78 |
ENST00000429457.1
|
AP1S1
|
adaptor-related protein complex 1, sigma 1 subunit |
chr1_+_43824669 | 1.77 |
ENST00000372462.1
|
CDC20
|
cell division cycle 20 |
chr11_-_93276582 | 1.77 |
ENST00000298966.2
|
SMCO4
|
single-pass membrane protein with coiled-coil domains 4 |
chr19_-_51472031 | 1.76 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
chr22_-_37915535 | 1.75 |
ENST00000403299.1
|
CARD10
|
caspase recruitment domain family, member 10 |
chr18_+_33877654 | 1.75 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
chr6_+_37137939 | 1.73 |
ENST00000373509.5
|
PIM1
|
pim-1 oncogene |
chr9_-_139891165 | 1.72 |
ENST00000494426.1
|
CLIC3
|
chloride intracellular channel 3 |
chr10_+_131265443 | 1.72 |
ENST00000306010.7
|
MGMT
|
O-6-methylguanine-DNA methyltransferase |
chr5_+_170288856 | 1.70 |
ENST00000523189.1
|
RANBP17
|
RAN binding protein 17 |
chr7_-_148581251 | 1.68 |
ENST00000478654.1
ENST00000460911.1 ENST00000350995.2 |
EZH2
|
enhancer of zeste homolog 2 (Drosophila) |
chr11_-_2170786 | 1.64 |
ENST00000300632.5
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr1_-_29450399 | 1.64 |
ENST00000521452.1
|
TMEM200B
|
transmembrane protein 200B |
chr15_-_91537723 | 1.62 |
ENST00000394249.3
ENST00000559811.1 ENST00000442656.2 ENST00000557905.1 ENST00000361919.3 |
PRC1
|
protein regulator of cytokinesis 1 |
chr18_+_5238055 | 1.62 |
ENST00000582363.1
ENST00000582008.1 ENST00000580082.1 |
LINC00667
|
long intergenic non-protein coding RNA 667 |
chr5_-_146833485 | 1.61 |
ENST00000398514.3
|
DPYSL3
|
dihydropyrimidinase-like 3 |
chrX_-_152939133 | 1.61 |
ENST00000370150.1
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
chr8_+_143761874 | 1.61 |
ENST00000301258.4
ENST00000513264.1 |
PSCA
|
prostate stem cell antigen |
chr7_-_149470540 | 1.61 |
ENST00000302017.3
|
ZNF467
|
zinc finger protein 467 |
chr5_-_60140089 | 1.61 |
ENST00000507047.1
ENST00000438340.1 ENST00000425382.1 ENST00000508821.1 |
ELOVL7
|
ELOVL fatty acid elongase 7 |
chr10_+_81466084 | 1.60 |
ENST00000342531.2
|
NUTM2B
|
NUT family member 2B |
chr7_-_143059845 | 1.60 |
ENST00000443739.2
|
FAM131B
|
family with sequence similarity 131, member B |
chr7_+_155089486 | 1.60 |
ENST00000340368.4
ENST00000344756.4 ENST00000425172.1 ENST00000342407.5 |
INSIG1
|
insulin induced gene 1 |
chr19_-_39226045 | 1.60 |
ENST00000597987.1
ENST00000595177.1 |
CAPN12
|
calpain 12 |
chr9_+_35829208 | 1.60 |
ENST00000439587.2
ENST00000377991.4 |
TMEM8B
|
transmembrane protein 8B |
chr14_-_92302825 | 1.60 |
ENST00000556018.1
|
TC2N
|
tandem C2 domains, nuclear |
chr16_+_89894875 | 1.60 |
ENST00000393062.2
|
SPIRE2
|
spire-type actin nucleation factor 2 |
chr19_-_49258606 | 1.59 |
ENST00000310160.3
|
FUT1
|
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group) |
chr19_-_55658650 | 1.59 |
ENST00000589226.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr11_-_61582579 | 1.58 |
ENST00000539419.1
ENST00000545245.1 ENST00000545405.1 ENST00000542506.1 |
FADS1
|
fatty acid desaturase 1 |
chr12_-_124018252 | 1.58 |
ENST00000376874.4
|
RILPL1
|
Rab interacting lysosomal protein-like 1 |
chr19_+_45281118 | 1.58 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
chrX_+_150151824 | 1.58 |
ENST00000455596.1
ENST00000448905.2 |
HMGB3
|
high mobility group box 3 |
chr12_-_49182783 | 1.58 |
ENST00000550422.1
|
ADCY6
|
adenylate cyclase 6 |
chr20_+_44637526 | 1.57 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
chr18_+_9334755 | 1.57 |
ENST00000262120.5
|
TWSG1
|
twisted gastrulation BMP signaling modulator 1 |
chr1_+_3689325 | 1.56 |
ENST00000444870.2
ENST00000452264.1 |
SMIM1
|
small integral membrane protein 1 (Vel blood group) |
chr17_-_34122596 | 1.56 |
ENST00000250144.8
|
MMP28
|
matrix metallopeptidase 28 |
chr3_+_160117418 | 1.56 |
ENST00000465903.1
ENST00000485645.1 ENST00000360111.2 ENST00000472991.1 ENST00000467468.1 ENST00000469762.1 ENST00000489573.1 ENST00000462787.1 ENST00000490207.1 ENST00000485867.1 |
SMC4
|
structural maintenance of chromosomes 4 |
chr11_+_46402744 | 1.55 |
ENST00000533952.1
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chr7_-_149470297 | 1.55 |
ENST00000484747.1
|
ZNF467
|
zinc finger protein 467 |
chr15_+_41624892 | 1.55 |
ENST00000260359.6
ENST00000450318.1 ENST00000450592.2 ENST00000559596.1 ENST00000414849.2 ENST00000560747.1 ENST00000560177.1 |
NUSAP1
|
nucleolar and spindle associated protein 1 |
chr11_+_66624527 | 1.54 |
ENST00000393952.3
|
LRFN4
|
leucine rich repeat and fibronectin type III domain containing 4 |
chr20_-_52210368 | 1.54 |
ENST00000371471.2
|
ZNF217
|
zinc finger protein 217 |
chr7_+_65670186 | 1.54 |
ENST00000304842.5
ENST00000442120.1 |
TPST1
|
tyrosylprotein sulfotransferase 1 |
chr11_-_2906979 | 1.54 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
chr11_-_105948040 | 1.53 |
ENST00000534815.1
|
KBTBD3
|
kelch repeat and BTB (POZ) domain containing 3 |
chr10_-_135171510 | 1.53 |
ENST00000278025.4
ENST00000368552.3 |
FUOM
|
fucose mutarotase |
chr19_-_291365 | 1.53 |
ENST00000591572.1
ENST00000269812.3 ENST00000434325.2 |
PPAP2C
|
phosphatidic acid phosphatase type 2C |
chr5_-_127873659 | 1.53 |
ENST00000262464.4
|
FBN2
|
fibrillin 2 |
chr19_-_46000251 | 1.53 |
ENST00000590526.1
ENST00000344680.4 ENST00000245923.4 |
RTN2
|
reticulon 2 |
chr2_+_10262857 | 1.52 |
ENST00000304567.5
|
RRM2
|
ribonucleotide reductase M2 |
chr20_+_62694834 | 1.52 |
ENST00000415602.1
|
TCEA2
|
transcription elongation factor A (SII), 2 |
chr21_+_40177755 | 1.52 |
ENST00000360938.3
ENST00000432278.1 |
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
chr3_-_16555150 | 1.52 |
ENST00000334133.4
|
RFTN1
|
raftlin, lipid raft linker 1 |
chr7_+_192969 | 1.52 |
ENST00000313766.5
|
FAM20C
|
family with sequence similarity 20, member C |
chr8_-_143867946 | 1.51 |
ENST00000301263.4
|
LY6D
|
lymphocyte antigen 6 complex, locus D |
chr2_-_160143242 | 1.51 |
ENST00000359774.4
|
WDSUB1
|
WD repeat, sterile alpha motif and U-box domain containing 1 |
chr1_-_6453426 | 1.51 |
ENST00000545482.1
|
ACOT7
|
acyl-CoA thioesterase 7 |
chr22_+_51112800 | 1.51 |
ENST00000414786.2
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3 |
chr20_+_62371206 | 1.51 |
ENST00000266077.2
|
SLC2A4RG
|
SLC2A4 regulator |
chr2_-_215674374 | 1.51 |
ENST00000449967.2
ENST00000421162.1 ENST00000260947.4 |
BARD1
|
BRCA1 associated RING domain 1 |
chr2_-_160143084 | 1.50 |
ENST00000409990.3
|
WDSUB1
|
WD repeat, sterile alpha motif and U-box domain containing 1 |
chr11_+_13690249 | 1.50 |
ENST00000532701.1
|
FAR1
|
fatty acyl CoA reductase 1 |
chr3_-_43663389 | 1.50 |
ENST00000444344.1
ENST00000456438.1 ENST00000350459.4 ENST00000396091.3 ENST00000451430.2 ENST00000428472.1 ENST00000414522.2 |
ANO10
|
anoctamin 10 |
chr19_-_51504411 | 1.50 |
ENST00000593490.1
|
KLK8
|
kallikrein-related peptidase 8 |
chr8_-_10588010 | 1.50 |
ENST00000304501.1
|
SOX7
|
SRY (sex determining region Y)-box 7 |
chr10_-_15210666 | 1.49 |
ENST00000378165.4
|
NMT2
|
N-myristoyltransferase 2 |
chr20_+_43374421 | 1.49 |
ENST00000372861.3
|
KCNK15
|
potassium channel, subfamily K, member 15 |
chr20_-_22565101 | 1.49 |
ENST00000419308.2
|
FOXA2
|
forkhead box A2 |
chr9_+_133971863 | 1.48 |
ENST00000372309.3
|
AIF1L
|
allograft inflammatory factor 1-like |
chr6_+_3000218 | 1.48 |
ENST00000380441.1
ENST00000380455.4 ENST00000380454.4 |
NQO2
|
NAD(P)H dehydrogenase, quinone 2 |
chr17_+_80709932 | 1.48 |
ENST00000355528.4
ENST00000397466.2 ENST00000539345.2 |
TBCD
|
tubulin folding cofactor D |
chr4_+_17812525 | 1.48 |
ENST00000251496.2
|
NCAPG
|
non-SMC condensin I complex, subunit G |
chr2_-_95825352 | 1.48 |
ENST00000295208.2
|
ZNF514
|
zinc finger protein 514 |
chr16_+_77246337 | 1.47 |
ENST00000563157.1
|
SYCE1L
|
synaptonemal complex central element protein 1-like |
chr3_-_43663519 | 1.47 |
ENST00000427171.1
ENST00000292246.3 |
ANO10
|
anoctamin 10 |
chr17_-_66453562 | 1.47 |
ENST00000262139.5
ENST00000546360.1 |
WIPI1
|
WD repeat domain, phosphoinositide interacting 1 |
chr8_+_26371763 | 1.47 |
ENST00000521913.1
|
DPYSL2
|
dihydropyrimidinase-like 2 |
chr4_-_99579733 | 1.46 |
ENST00000305798.3
|
TSPAN5
|
tetraspanin 5 |
chr7_+_36429424 | 1.46 |
ENST00000396068.2
|
ANLN
|
anillin, actin binding protein |
chr1_+_37940153 | 1.46 |
ENST00000373087.6
|
ZC3H12A
|
zinc finger CCCH-type containing 12A |
chr4_+_75310851 | 1.46 |
ENST00000395748.3
ENST00000264487.2 |
AREG
|
amphiregulin |
chr19_-_55658281 | 1.45 |
ENST00000585321.2
ENST00000587465.2 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr5_+_153570319 | 1.45 |
ENST00000377661.2
|
GALNT10
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10) |
chr19_+_6531010 | 1.45 |
ENST00000245817.3
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9 |
chr16_-_85784557 | 1.45 |
ENST00000602675.1
|
C16orf74
|
chromosome 16 open reading frame 74 |
chr7_-_65447192 | 1.45 |
ENST00000421103.1
ENST00000345660.6 ENST00000304895.4 |
GUSB
|
glucuronidase, beta |
chr19_-_40971667 | 1.44 |
ENST00000263368.4
|
BLVRB
|
biliverdin reductase B (flavin reductase (NADPH)) |
chr20_-_43280325 | 1.44 |
ENST00000537820.1
|
ADA
|
adenosine deaminase |
chr2_-_160143158 | 1.44 |
ENST00000409124.1
ENST00000358147.4 |
WDSUB1
|
WD repeat, sterile alpha motif and U-box domain containing 1 |
chr7_-_156685890 | 1.44 |
ENST00000353442.5
|
LMBR1
|
limb development membrane protein 1 |
chr1_-_9189229 | 1.44 |
ENST00000377411.4
|
GPR157
|
G protein-coupled receptor 157 |
chr19_-_55919087 | 1.44 |
ENST00000587845.1
ENST00000589978.1 ENST00000264552.9 |
UBE2S
|
ubiquitin-conjugating enzyme E2S |
chr17_+_7155819 | 1.44 |
ENST00000570322.1
ENST00000576496.1 ENST00000574841.2 |
ELP5
|
elongator acetyltransferase complex subunit 5 |
chr7_+_36429409 | 1.43 |
ENST00000265748.2
|
ANLN
|
anillin, actin binding protein |
chr6_-_99797522 | 1.43 |
ENST00000389677.5
|
FAXC
|
failed axon connections homolog (Drosophila) |
chr17_+_76210367 | 1.43 |
ENST00000592734.1
ENST00000587746.1 |
BIRC5
|
baculoviral IAP repeat containing 5 |
chr11_+_2923423 | 1.42 |
ENST00000312221.5
|
SLC22A18
|
solute carrier family 22, member 18 |
chr3_+_121554046 | 1.42 |
ENST00000273668.2
ENST00000451944.2 |
EAF2
|
ELL associated factor 2 |
chr11_+_46402583 | 1.42 |
ENST00000359803.3
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chrY_-_297445 | 1.42 |
ENSTR0000390665.3
|
PPP2R3B
|
protein phosphatase 2, regulatory subunit B'', beta |
chr19_-_40971643 | 1.41 |
ENST00000595483.1
|
BLVRB
|
biliverdin reductase B (flavin reductase (NADPH)) |
chr18_+_657578 | 1.41 |
ENST00000323274.10
|
TYMS
|
thymidylate synthetase |
chr11_+_76778033 | 1.41 |
ENST00000456580.2
|
CAPN5
|
calpain 5 |
chr5_-_171881491 | 1.41 |
ENST00000311601.5
|
SH3PXD2B
|
SH3 and PX domains 2B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.4 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
2.3 | 9.3 | GO:0009447 | putrescine catabolic process(GO:0009447) |
1.7 | 5.2 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
1.3 | 4.0 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
1.2 | 4.9 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
1.2 | 3.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
1.2 | 3.6 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
1.2 | 6.9 | GO:0030421 | defecation(GO:0030421) |
1.1 | 1.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
1.1 | 6.9 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
1.1 | 3.3 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
1.1 | 10.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.0 | 4.1 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.0 | 4.1 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
1.0 | 4.0 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.0 | 2.9 | GO:2000775 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
1.0 | 2.9 | GO:1904172 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
0.9 | 2.8 | GO:0042938 | dipeptide transport(GO:0042938) |
0.9 | 2.8 | GO:0019860 | uracil metabolic process(GO:0019860) |
0.9 | 2.8 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.9 | 3.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.9 | 2.7 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.9 | 0.9 | GO:0097102 | endothelial tip cell fate specification(GO:0097102) |
0.9 | 2.6 | GO:0071810 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
0.9 | 3.5 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.9 | 2.6 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.8 | 2.5 | GO:0046103 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
0.8 | 5.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.8 | 2.5 | GO:0097187 | dentinogenesis(GO:0097187) |
0.8 | 2.4 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.8 | 2.4 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.8 | 3.1 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
0.8 | 3.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.8 | 3.0 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.8 | 2.3 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.8 | 2.3 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.7 | 6.3 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.7 | 2.1 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.7 | 3.3 | GO:1905071 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
0.6 | 1.9 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.6 | 2.6 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.6 | 8.4 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.6 | 5.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.6 | 1.9 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.6 | 4.4 | GO:0016129 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.6 | 1.8 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.6 | 3.6 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.6 | 0.6 | GO:0003213 | cardiac right atrium morphogenesis(GO:0003213) |
0.6 | 1.8 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.6 | 1.7 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.6 | 5.2 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.6 | 1.7 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.6 | 2.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.5 | 0.5 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.5 | 3.3 | GO:0060717 | chorion development(GO:0060717) |
0.5 | 0.5 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.5 | 4.3 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.5 | 3.2 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.5 | 1.6 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.5 | 4.2 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.5 | 2.1 | GO:0019427 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.5 | 0.5 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.5 | 2.6 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.5 | 1.5 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
0.5 | 0.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.5 | 2.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.5 | 1.5 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.5 | 0.5 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.5 | 2.0 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.5 | 2.0 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
0.5 | 2.5 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.5 | 2.5 | GO:0015862 | uridine transport(GO:0015862) |
0.5 | 8.3 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.5 | 1.5 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.5 | 0.5 | GO:1901094 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.5 | 1.9 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
0.5 | 0.5 | GO:2001037 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.5 | 0.9 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.5 | 0.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.5 | 2.8 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.5 | 1.4 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.5 | 2.3 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.5 | 1.4 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.5 | 1.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.5 | 1.8 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
0.5 | 0.5 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.4 | 3.6 | GO:0046618 | drug export(GO:0046618) |
0.4 | 1.3 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
0.4 | 2.2 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
0.4 | 2.6 | GO:0043585 | nose morphogenesis(GO:0043585) |
0.4 | 4.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.4 | 2.6 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.4 | 0.9 | GO:0036100 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) long-chain fatty acid catabolic process(GO:0042758) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.4 | 1.7 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.4 | 0.4 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.4 | 1.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.4 | 1.7 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.4 | 1.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.4 | 5.0 | GO:0033227 | dsRNA transport(GO:0033227) |
0.4 | 3.3 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.4 | 1.7 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.4 | 1.6 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.4 | 4.9 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.4 | 1.2 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.4 | 6.1 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.4 | 1.2 | GO:0070632 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.4 | 4.8 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.4 | 4.4 | GO:0061042 | vascular wound healing(GO:0061042) |
0.4 | 1.2 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.4 | 1.6 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.4 | 2.0 | GO:0019075 | virus maturation(GO:0019075) |
0.4 | 1.2 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
0.4 | 2.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.4 | 2.7 | GO:0060992 | response to fungicide(GO:0060992) |
0.4 | 4.6 | GO:0048102 | autophagic cell death(GO:0048102) |
0.4 | 1.9 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.4 | 1.5 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.4 | 1.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.4 | 2.7 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.4 | 1.1 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.4 | 1.1 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.4 | 1.1 | GO:0090135 | actin filament branching(GO:0090135) |
0.4 | 1.1 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.4 | 2.6 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.4 | 1.8 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.4 | 1.8 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.4 | 1.1 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.4 | 1.1 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.4 | 1.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.4 | 2.2 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.4 | 1.1 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.4 | 0.7 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.4 | 2.1 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.4 | 1.8 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.4 | 1.1 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.4 | 1.8 | GO:0060356 | leucine import(GO:0060356) |
0.4 | 1.1 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.4 | 0.4 | GO:0071373 | cellular response to luteinizing hormone stimulus(GO:0071373) |
0.4 | 1.1 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.4 | 3.2 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.3 | 1.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.3 | 3.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 1.4 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
0.3 | 1.0 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.3 | 2.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 1.0 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
0.3 | 1.0 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.3 | 1.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 1.0 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.3 | 1.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 1.3 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.3 | 3.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.3 | 2.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 3.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 1.3 | GO:0071484 | cellular response to light intensity(GO:0071484) |
0.3 | 1.0 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.3 | 1.0 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
0.3 | 1.0 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.3 | 2.0 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.3 | 2.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 0.7 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.3 | 1.0 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.3 | 2.9 | GO:0051383 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.3 | 1.0 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
0.3 | 0.7 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.3 | 1.0 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.3 | 1.6 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.3 | 0.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 2.6 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.3 | 2.6 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.3 | 0.3 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.3 | 0.3 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.3 | 2.2 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.3 | 2.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 1.3 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.3 | 0.9 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.3 | 0.6 | GO:0051665 | membrane raft localization(GO:0051665) |
0.3 | 1.6 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.3 | 0.9 | GO:0071529 | cementum mineralization(GO:0071529) |
0.3 | 1.6 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 1.9 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.3 | 0.9 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.3 | 0.3 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.3 | 2.2 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.3 | 6.8 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.3 | 4.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.3 | 1.8 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.3 | 2.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 0.6 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.3 | 0.9 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
0.3 | 3.7 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.3 | 1.5 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.3 | 0.3 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.3 | 0.6 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.3 | 0.9 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.3 | 0.3 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.3 | 1.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 0.9 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
0.3 | 0.3 | GO:0032680 | regulation of tumor necrosis factor production(GO:0032680) |
0.3 | 2.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.3 | 0.9 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.3 | 7.4 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.3 | 0.6 | GO:0070638 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.3 | 1.8 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.3 | 0.9 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.3 | 1.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 2.0 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
0.3 | 2.0 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.3 | 0.9 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.3 | 0.9 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.3 | 0.6 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.3 | 0.9 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 1.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.3 | 1.2 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.3 | 0.6 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.3 | 0.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 0.6 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 3.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.3 | 4.6 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 0.3 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.3 | 0.3 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.3 | 0.8 | GO:0048597 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.3 | 1.1 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.3 | 2.8 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 1.1 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.3 | 1.1 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.3 | 1.7 | GO:0007498 | mesoderm development(GO:0007498) |
0.3 | 0.8 | GO:0046080 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
0.3 | 0.8 | GO:1902081 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.3 | 0.8 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.3 | 0.6 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.3 | 1.1 | GO:0044334 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.3 | 0.8 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.3 | 1.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.3 | 3.5 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.3 | 0.8 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.3 | 1.9 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.3 | 0.8 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.3 | 0.8 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.3 | 0.8 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.3 | 1.9 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 1.3 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.3 | 5.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 0.8 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.3 | 5.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 0.5 | GO:0090182 | regulation of secretion of lysosomal enzymes(GO:0090182) |
0.3 | 0.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.3 | 1.1 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.3 | 1.1 | GO:0042853 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
0.3 | 1.3 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.3 | 1.6 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.3 | 0.3 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.3 | 0.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 1.3 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
0.3 | 1.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 0.3 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.3 | 0.8 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.3 | 1.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 0.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.3 | 3.1 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.3 | 0.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.3 | 0.8 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.3 | 1.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 1.5 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.3 | 1.8 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 0.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 1.0 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
0.3 | 0.3 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.3 | 1.3 | GO:0051946 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
0.3 | 1.8 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
0.3 | 1.3 | GO:1904744 | regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
0.3 | 0.5 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.2 | 1.7 | GO:0006868 | glutamine transport(GO:0006868) |
0.2 | 1.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.2 | 1.7 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.2 | 0.7 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.2 | 1.0 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.2 | 1.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.2 | 3.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 1.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 2.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 1.0 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.2 | 0.2 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.2 | 0.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 0.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 3.6 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 1.4 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.2 | 0.2 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
0.2 | 1.2 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.2 | 1.0 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.2 | 0.7 | GO:0030903 | notochord development(GO:0030903) |
0.2 | 3.5 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.2 | 3.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 0.5 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.2 | 0.9 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.2 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.2 | 6.0 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.2 | 0.2 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.2 | 0.7 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.2 | 2.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.2 | GO:1903147 | negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
0.2 | 0.7 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.2 | 0.9 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.2 | 0.5 | GO:0060998 | regulation of dendritic spine development(GO:0060998) |
0.2 | 1.8 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 1.6 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 0.7 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.2 | 0.7 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.2 | 2.0 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 1.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 0.5 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.2 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.2 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 0.9 | GO:1904978 | regulation of endosome organization(GO:1904978) |
0.2 | 0.9 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.2 | 1.3 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.2 | 0.4 | GO:0035669 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
0.2 | 0.2 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
0.2 | 0.2 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.2 | 2.0 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 2.7 | GO:0051231 | spindle elongation(GO:0051231) |
0.2 | 5.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 0.9 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.2 | 1.5 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.2 | 0.7 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 4.4 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 0.9 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 0.4 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.2 | 1.3 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 3.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 1.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 4.3 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.2 | 2.8 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 0.6 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.2 | 2.6 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.2 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.2 | 0.9 | GO:0009386 | translational attenuation(GO:0009386) |
0.2 | 0.4 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.2 | 3.9 | GO:0051608 | histamine transport(GO:0051608) |
0.2 | 0.4 | GO:2000412 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) positive regulation of thymocyte migration(GO:2000412) |
0.2 | 0.2 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
0.2 | 0.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 9.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.2 | 1.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.6 | GO:0044805 | late nucleophagy(GO:0044805) |
0.2 | 0.2 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 0.6 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.2 | 1.5 | GO:0070305 | response to cGMP(GO:0070305) |
0.2 | 1.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 0.8 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.2 | 0.8 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.2 | 0.2 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.2 | 2.7 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.2 | 11.0 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.2 | 3.1 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.2 | 2.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.2 | 0.4 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.2 | 0.8 | GO:0010266 | response to vitamin B1(GO:0010266) |
0.2 | 1.4 | GO:0007135 | meiosis II(GO:0007135) |
0.2 | 1.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 0.2 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 1.8 | GO:0003264 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
0.2 | 0.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.2 | 1.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 0.4 | GO:0060214 | endocardium formation(GO:0060214) |
0.2 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.6 | GO:0003157 | endocardium development(GO:0003157) |
0.2 | 0.4 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.2 | 1.8 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.2 | 1.0 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.2 | 0.6 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
0.2 | 2.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.2 | 0.8 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.2 | 2.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 0.6 | GO:0006272 | leading strand elongation(GO:0006272) |
0.2 | 0.8 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 1.0 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.4 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.2 | 0.2 | GO:0010332 | response to gamma radiation(GO:0010332) |
0.2 | 1.8 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 0.2 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.2 | 0.6 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
0.2 | 3.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 1.4 | GO:0021564 | vagus nerve development(GO:0021564) |
0.2 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 1.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.8 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.2 | 1.0 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
0.2 | 2.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 1.8 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 2.9 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.2 | 0.2 | GO:1902527 | regulation of protein monoubiquitination(GO:1902525) positive regulation of protein monoubiquitination(GO:1902527) |
0.2 | 1.8 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.2 | 1.4 | GO:0097338 | response to clozapine(GO:0097338) |
0.2 | 1.0 | GO:1902228 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.2 | 0.8 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
0.2 | 2.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 0.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.2 | 0.8 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.2 | 0.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.2 | 0.8 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.2 | 1.3 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 1.0 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.2 | 0.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.2 | 1.5 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.2 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.2 | 1.5 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.2 | 1.5 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.2 | 13.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.8 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.2 | 0.6 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.2 | 0.8 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.2 | 0.2 | GO:2000791 | regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
0.2 | 0.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 0.2 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.2 | 0.6 | GO:0035690 | cellular response to drug(GO:0035690) |
0.2 | 1.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 1.5 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.2 | 0.6 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 1.1 | GO:0000050 | urea cycle(GO:0000050) |
0.2 | 0.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 1.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.9 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
0.2 | 5.3 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 0.2 | GO:2001303 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.2 | 2.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 2.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 2.2 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 0.5 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.2 | 0.5 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 0.5 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.2 | 0.9 | GO:1903412 | response to bile acid(GO:1903412) |
0.2 | 0.5 | GO:0070295 | renal water absorption(GO:0070295) |
0.2 | 0.4 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.2 | 0.7 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.7 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.2 | 0.5 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.2 | 1.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 0.5 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.2 | 0.7 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
0.2 | 1.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.2 | 0.2 | GO:1905064 | negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
0.2 | 0.9 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.2 | 0.5 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.2 | 4.2 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.2 | 0.5 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.2 | 0.9 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 1.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 0.9 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.2 | 1.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 1.6 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.2 | 4.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 1.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.5 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.2 | 1.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.5 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
0.2 | 0.9 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 0.9 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.2 | 0.2 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.2 | 0.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.2 | 0.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.2 | 1.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 1.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 0.3 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.2 | 0.5 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.2 | 0.5 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.2 | 0.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.2 | 0.7 | GO:1904647 | response to rotenone(GO:1904647) |
0.2 | 0.7 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.2 | 2.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 1.0 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.2 | 0.2 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.2 | 0.5 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.2 | 0.2 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.2 | 0.3 | GO:2000286 | regulation of endosome size(GO:0051036) receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.2 | 0.8 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.2 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.3 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.2 | 0.2 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.2 | 0.5 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
0.2 | 0.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.2 | 0.3 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.2 | 0.2 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.2 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.5 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 1.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 1.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 1.5 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.2 | 2.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.2 | GO:0001832 | blastocyst growth(GO:0001832) |
0.2 | 3.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 0.5 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.2 | 1.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 1.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.2 | 0.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 2.4 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 0.8 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.2 | 0.6 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 1.0 | GO:0036017 | response to erythropoietin(GO:0036017) |
0.2 | 0.3 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.2 | 0.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 0.5 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.2 | 1.7 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.3 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.2 | 1.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.6 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.2 | 0.5 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.2 | 0.2 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.2 | 0.5 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.2 | 3.5 | GO:0043476 | pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) |
0.2 | 0.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.2 | 3.2 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.2 | 0.2 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 2.1 | GO:0035878 | nail development(GO:0035878) |
0.2 | 0.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.5 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.2 | 3.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 1.5 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.2 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.2 | 0.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 0.2 | GO:1902822 | regulation of late endosome to lysosome transport(GO:1902822) |
0.2 | 0.3 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
0.2 | 0.8 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.2 | 0.3 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
0.2 | 0.2 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
0.2 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.6 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 1.6 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.1 | 0.6 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 0.1 | GO:0071030 | nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
0.1 | 4.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 1.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 1.5 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.1 | 1.8 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.4 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.1 | 0.6 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 2.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.7 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.1 | 0.9 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.7 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.1 | 1.6 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.4 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
0.1 | 0.9 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.1 | 0.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.3 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.1 | 0.9 | GO:0006574 | valine catabolic process(GO:0006574) |
0.1 | 0.4 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.1 | 0.9 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.1 | 1.4 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.3 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 1.0 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.4 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 0.7 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.1 | 0.6 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.6 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 0.4 | GO:0060721 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.1 | 2.8 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.3 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.1 | 1.3 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.1 | 0.1 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.1 | 0.1 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.1 | 0.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 5.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 2.9 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 1.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 1.3 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 1.3 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.1 | 1.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 1.1 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.1 | 0.3 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.1 | 1.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.1 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.1 | 0.3 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.3 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.1 | GO:1902218 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) |
0.1 | 0.4 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.4 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 | 0.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.4 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 1.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.1 | 3.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.3 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.1 | 0.7 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.3 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 2.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.4 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.1 | 0.7 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.1 | 1.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 1.5 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.1 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.1 | 0.5 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.1 | 0.1 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.1 | 2.9 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.3 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.1 | 1.1 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 1.1 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.1 | 0.8 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 2.6 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.7 | GO:0044070 | regulation of anion transport(GO:0044070) |
0.1 | 0.4 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.4 | GO:1904238 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
0.1 | 0.8 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.3 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 0.3 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.1 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
0.1 | 0.8 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.9 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.5 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 1.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.8 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.6 | GO:0072248 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.1 | 1.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.3 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.1 | 1.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.6 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.3 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.1 | 0.5 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
0.1 | 0.5 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 0.9 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.1 | 0.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.6 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 1.9 | GO:0098868 | bone growth(GO:0098868) |
0.1 | 0.1 | GO:1990834 | response to odorant(GO:1990834) |
0.1 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.3 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 0.8 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.1 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.5 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.1 | 0.2 | GO:0061290 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.1 | 0.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.4 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.5 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 1.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.7 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.1 | 0.4 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.1 | 1.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 1.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.1 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.1 | GO:0001941 | postsynaptic membrane organization(GO:0001941) |
0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.4 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.1 | 0.4 | GO:0035350 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
0.1 | 0.4 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.4 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.4 | GO:0007538 | primary sex determination(GO:0007538) |
0.1 | 5.4 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 1.0 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 3.9 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.1 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.1 | 0.1 | GO:0010891 | regulation of sequestering of triglyceride(GO:0010889) negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.4 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.1 | 0.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.1 | 0.7 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.4 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.1 | 0.4 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.1 | 0.1 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.1 | 0.6 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.4 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.1 | 0.5 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.4 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.1 | 0.3 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.1 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.1 | 0.8 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.9 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.1 | GO:1905216 | positive regulation of RNA binding(GO:1905216) |
0.1 | 0.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 1.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.2 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 1.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 1.6 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.5 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.1 | 1.9 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.7 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 0.5 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.1 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.3 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.1 | 1.2 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.2 | GO:1901656 | glycoside transport(GO:1901656) |
0.1 | 2.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.6 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.4 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.1 | 0.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 1.1 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 2.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 1.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.4 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.1 | 0.8 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.3 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 0.4 | GO:0072114 | pronephros morphogenesis(GO:0072114) |
0.1 | 0.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.9 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.4 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.1 | 0.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 0.4 | GO:0015870 | acetylcholine transport(GO:0015870) |
0.1 | 0.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 2.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 1.0 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.2 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 1.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.1 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.8 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.3 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.1 | 1.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.1 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.1 | 0.5 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.2 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.6 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.4 | GO:0046449 | creatinine metabolic process(GO:0046449) |
0.1 | 1.3 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.2 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
0.1 | 0.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.1 | 0.7 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.7 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 2.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.4 | GO:0046015 | regulation of transcription by glucose(GO:0046015) positive regulation of transcription by glucose(GO:0046016) |
0.1 | 0.4 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.1 | 3.5 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 1.9 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.1 | 1.3 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 3.6 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 0.7 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.2 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.1 | 0.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 1.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.5 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.3 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.1 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 1.0 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) |
0.1 | 1.9 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 0.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.1 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.1 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.1 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 1.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 1.8 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.5 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.1 | 1.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.7 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.1 | 0.3 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.1 | 0.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 0.7 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.1 | 0.5 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 1.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.2 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.1 | 0.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.6 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.5 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 0.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.8 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.1 | 0.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 5.1 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.1 | 0.1 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 7.7 | GO:0000725 | recombinational repair(GO:0000725) |
0.1 | 1.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.3 | GO:0050894 | determination of affect(GO:0050894) |
0.1 | 1.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 1.6 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 0.3 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 0.3 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.1 | 0.5 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.3 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.1 | 0.4 | GO:0042220 | response to cocaine(GO:0042220) |
0.1 | 0.4 | GO:0044211 | CTP salvage(GO:0044211) |
0.1 | 0.1 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.1 | 0.3 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
0.1 | 0.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.1 | 1.8 | GO:0090307 | mitotic spindle assembly(GO:0090307) |
0.1 | 1.3 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.1 | 0.4 | GO:0051875 | pigment granule localization(GO:0051875) |
0.1 | 0.6 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
0.1 | 0.6 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 0.1 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.1 | 0.3 | GO:0045333 | cellular respiration(GO:0045333) |
0.1 | 0.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.8 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 | 0.9 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 0.2 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.1 | 2.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.3 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.1 | 0.4 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.1 | 2.5 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.1 | 0.1 | GO:0098722 | asymmetric stem cell division(GO:0098722) |
0.1 | 0.8 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.1 | 0.1 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.1 | 0.4 | GO:0021557 | optic vesicle morphogenesis(GO:0003404) oculomotor nerve development(GO:0021557) |
0.1 | 0.5 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.1 | 0.4 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.5 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.3 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.4 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 0.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.5 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.1 | 0.6 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.2 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.1 | 0.4 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.1 | 0.4 | GO:0002880 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
0.1 | 0.6 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.8 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.1 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 2.4 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.1 | 1.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.2 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.5 | GO:0048296 | regulation of isotype switching to IgA isotypes(GO:0048296) |
0.1 | 0.4 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.6 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.1 | 0.4 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.1 | 0.9 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.7 | GO:0072386 | plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.4 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.1 | 0.6 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.3 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.1 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.5 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 3.2 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.6 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.1 | 0.1 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.1 | 0.7 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 0.7 | GO:0051189 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.4 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.9 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 0.6 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.1 | 0.5 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.8 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 0.4 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.1 | 1.2 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.3 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.4 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.1 | 0.3 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 0.1 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 1.5 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 2.6 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 0.5 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 1.2 | GO:0032392 | DNA geometric change(GO:0032392) |
0.1 | 0.2 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 0.2 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.1 | GO:0007127 | meiosis I(GO:0007127) |
0.1 | 0.6 | GO:0042262 | DNA protection(GO:0042262) |
0.1 | 0.2 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.1 | 0.2 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 3.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.3 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.1 | 0.2 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 0.2 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.9 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.1 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.1 | 0.5 | GO:1900740 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) protein insertion into mitochondrial membrane(GO:0051204) regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.1 | 0.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.2 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.1 | 1.0 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.6 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.2 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.1 | 0.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.6 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 1.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.2 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.1 | 0.5 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 3.4 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.9 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.2 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.1 | 0.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.2 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 1.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 3.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.3 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.1 | 0.1 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.1 | 0.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.2 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) |
0.1 | 0.3 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.6 | GO:0001893 | maternal placenta development(GO:0001893) |
0.1 | 1.4 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.1 | 0.4 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.1 | 0.2 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.1 | 0.8 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.5 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 | 1.7 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 3.5 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.6 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.1 | 0.3 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.1 | 0.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.3 | GO:1902961 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.1 | 1.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.2 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
0.1 | 2.2 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 1.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.3 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.2 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.1 | 0.5 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.4 | GO:0006623 | protein targeting to vacuole(GO:0006623) establishment of protein localization to vacuole(GO:0072666) |
0.1 | 0.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 1.4 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.4 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.2 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.1 | 0.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.6 | GO:0051597 | response to methylmercury(GO:0051597) |
0.1 | 2.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.4 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.9 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 1.8 | GO:0097502 | mannosylation(GO:0097502) |
0.1 | 0.1 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.1 | 0.1 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.1 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.1 | 0.2 | GO:0002188 | translation reinitiation(GO:0002188) |
0.1 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.1 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.1 | 0.2 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 8.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.3 | GO:0007099 | centriole replication(GO:0007099) |
0.1 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.1 | GO:0048625 | myoblast fate determination(GO:0007518) myoblast fate commitment(GO:0048625) |
0.1 | 0.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.3 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.1 | 1.0 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 1.9 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.2 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.1 | 0.1 | GO:0046707 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
0.1 | 0.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.5 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.4 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.1 | GO:0002353 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
0.1 | 0.3 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.1 | 0.2 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.1 | 0.3 | GO:0015692 | lead ion transport(GO:0015692) |
0.1 | 0.1 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
0.1 | 0.2 | GO:0046203 | spermidine catabolic process(GO:0046203) |
0.1 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.8 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.4 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.1 | GO:0019563 | glycerol catabolic process(GO:0019563) |
0.1 | 0.1 | GO:0045661 | regulation of myoblast differentiation(GO:0045661) |
0.1 | 3.9 | GO:0000819 | sister chromatid segregation(GO:0000819) |
0.1 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.3 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 3.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.5 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.1 | 0.2 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.1 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 0.1 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.1 | 0.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
0.1 | 0.2 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 0.2 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.1 | 0.1 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.1 | 0.3 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.1 | 0.3 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 2.3 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.1 | GO:0030047 | actin modification(GO:0030047) |
0.1 | 0.2 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.3 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.1 | 0.1 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 0.3 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.1 | 0.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0048793 | pronephros development(GO:0048793) |
0.1 | 0.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.1 | 0.9 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.1 | 1.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.7 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.1 | GO:0051439 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
0.1 | 0.3 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.1 | 0.3 | GO:0032048 | cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) |
0.1 | 1.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.1 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.4 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.2 | GO:0045778 | positive regulation of ossification(GO:0045778) |
0.1 | 0.2 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 1.0 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.1 | 0.4 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.1 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
0.1 | 0.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.2 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.4 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.2 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.9 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) |
0.1 | 0.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.1 | 0.1 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.1 | 0.1 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.2 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.1 | 0.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 0.2 | GO:0001890 | placenta development(GO:0001890) |
0.1 | 0.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.1 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 0.4 | GO:0071871 | response to epinephrine(GO:0071871) |
0.1 | 0.4 | GO:0060324 | face development(GO:0060324) |
0.1 | 0.1 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.7 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.1 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.1 | 0.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 0.4 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.4 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.2 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.1 | 0.3 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.1 | 0.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.8 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.1 | 0.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.1 | 0.3 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.2 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.1 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.7 | GO:0044786 | cell cycle DNA replication(GO:0044786) |
0.1 | 0.4 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.1 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 0.3 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.1 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.3 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.6 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 0.6 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.1 | 0.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.3 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.1 | 0.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.1 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.1 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.1 | 0.2 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.2 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.1 | 0.2 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.2 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
0.1 | 0.3 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.4 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.2 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.1 | 0.1 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.1 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.1 | 0.2 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.3 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.2 | GO:0044254 | angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
0.1 | 0.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.7 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.8 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 1.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.1 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.1 | 0.6 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 0.3 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.5 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 0.2 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.1 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.1 | 0.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 1.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.1 | 0.3 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.1 | 0.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.2 | GO:0006195 | purine nucleotide catabolic process(GO:0006195) |
0.1 | 0.1 | GO:0021781 | glial cell fate commitment(GO:0021781) |
0.1 | 0.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.1 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
0.1 | 0.3 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.1 | GO:0060490 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.1 | 3.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.5 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.1 | 0.5 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.1 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.1 | 1.7 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.3 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.1 | 0.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 0.1 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.1 | 0.1 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.2 | GO:0033135 | regulation of peptidyl-serine phosphorylation(GO:0033135) |
0.1 | 0.2 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
0.1 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.2 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.1 | 1.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.9 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.2 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.0 | 1.3 | GO:0072413 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.0 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.2 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.0 | 0.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 0.1 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.0 | 0.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 1.1 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.0 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 1.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 3.2 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.2 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 0.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.3 | GO:0002931 | response to ischemia(GO:0002931) |
0.0 | 0.3 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.5 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.2 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.0 | 0.0 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.0 | 0.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.1 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.0 | 0.6 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.2 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.0 | 0.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.4 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.0 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
0.0 | 0.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 1.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 1.7 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 1.0 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.2 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
0.0 | 0.8 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.1 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.0 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.6 | GO:0042476 | odontogenesis(GO:0042476) |
0.0 | 0.0 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.1 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.0 | 1.0 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.0 | 0.0 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
0.0 | 0.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.3 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.0 | 0.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.0 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
0.0 | 0.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.1 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.0 | 0.3 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.1 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.1 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.1 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.0 | 0.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.0 | 0.0 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.0 | 0.1 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.0 | 0.0 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
0.0 | 0.4 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.0 | 0.0 | GO:0035349 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.0 | 0.1 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.2 | GO:0050666 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
0.0 | 0.2 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.0 | 0.1 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.0 | 0.1 | GO:0044346 | fibroblast apoptotic process(GO:0044346) |
0.0 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.0 | GO:0060525 | prostate glandular acinus development(GO:0060525) prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.0 | 0.4 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.2 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.0 | 0.8 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.0 | 0.1 | GO:0033363 | acrosome assembly(GO:0001675) secretory granule organization(GO:0033363) |
0.0 | 0.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.5 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.0 | 0.3 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.0 | GO:1904730 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
0.0 | 0.2 | GO:0003069 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.8 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.0 | 0.1 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.1 | GO:0060139 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
0.0 | 0.1 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.0 | 0.1 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.0 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.1 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.0 | 0.2 | GO:0046643 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation(GO:0046643) negative regulation of CD8-positive, alpha-beta T cell activation(GO:2001186) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
0.0 | 0.7 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.0 | 0.2 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.3 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.1 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.0 | 0.1 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
0.0 | 0.1 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.0 | 0.1 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.0 | 0.0 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.0 | 0.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 0.9 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.0 | 0.5 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.6 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.7 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.3 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.0 | 0.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.2 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.1 | GO:2001176 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.0 | 0.4 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.0 | 0.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 1.0 | GO:0006505 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.2 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.2 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.0 | 1.0 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.0 | 0.2 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.4 | GO:0098761 | interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
0.0 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.3 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.1 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.2 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.0 | 0.2 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 | 0.0 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.5 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
0.0 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.1 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.0 | 0.0 | GO:2000197 | regulation of ribonucleoprotein complex localization(GO:2000197) |
0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.0 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.7 | GO:0038034 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.0 | 0.6 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.1 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.0 | 0.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.1 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.3 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.0 | 0.1 | GO:0051781 | positive regulation of cell division(GO:0051781) |
0.0 | 0.3 | GO:0060348 | bone development(GO:0060348) |
0.0 | 0.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.5 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 0.1 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.0 | 0.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.1 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.0 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.0 | 0.4 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.0 | 0.1 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.0 | 0.0 | GO:0009651 | response to salt stress(GO:0009651) |
0.0 | 0.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 1.3 | GO:0003229 | ventricular cardiac muscle tissue development(GO:0003229) |
0.0 | 0.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.0 | 0.0 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.0 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.0 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.0 | 0.0 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 1.7 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.4 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.1 | GO:0070944 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
0.0 | 0.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 0.1 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.0 | 0.1 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
0.0 | 0.0 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.0 | 0.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.1 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
0.0 | 0.4 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.0 | 0.0 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.0 | 0.5 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 0.2 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.0 | 0.2 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.1 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.0 | 0.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.0 | 0.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.0 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.1 | GO:1904467 | regulation of tumor necrosis factor secretion(GO:1904467) positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.0 | 0.1 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.0 | 0.1 | GO:1903203 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) |
0.0 | 0.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 1.3 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.0 | 4.2 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.2 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.2 | GO:0060004 | reflex(GO:0060004) |
0.0 | 1.0 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.0 | 0.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.0 | 0.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.0 | 0.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.0 | 0.0 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
0.0 | 0.2 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
0.0 | 0.0 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.0 | 0.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.1 | GO:0032615 | interleukin-12 production(GO:0032615) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.0 | GO:0051031 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
0.0 | 0.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.6 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.0 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.0 | 0.1 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.0 | 1.3 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 0.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.0 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 3.2 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.1 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.2 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.0 | 0.1 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.0 | 0.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.1 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 0.4 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.0 | 2.3 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.0 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.0 | 0.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.0 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.1 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.1 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.0 | 0.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.2 | GO:0021515 | cell differentiation in spinal cord(GO:0021515) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.0 | 0.0 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.0 | 0.0 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 0.0 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 1.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:1990523 | bone regeneration(GO:1990523) |
0.0 | 0.0 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.0 | 0.0 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
0.0 | 1.1 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.0 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.0 | 0.1 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.1 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.0 | 0.0 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.0 | 0.0 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.0 | 0.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 2.0 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.2 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.1 | GO:0090175 | regulation of establishment of planar polarity(GO:0090175) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.3 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.2 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.0 | 1.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.5 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.0 | 0.4 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.4 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.2 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.4 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.6 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.3 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.0 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0035107 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
0.0 | 0.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.0 | 0.4 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.0 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.1 | GO:0046222 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.0 | 1.6 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.1 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.0 | 0.0 | GO:0010939 | regulation of necrotic cell death(GO:0010939) |
0.0 | 0.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0036337 | Fas signaling pathway(GO:0036337) regulation of Fas signaling pathway(GO:1902044) |
0.0 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.0 | GO:0072343 | pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) |
0.0 | 0.1 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.0 | 0.1 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.0 | 0.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.0 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.0 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.0 | 0.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) regulation of viral transcription(GO:0046782) |
0.0 | 0.0 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.0 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.0 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.2 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.2 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.4 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.0 | GO:0099563 | modification of synaptic structure(GO:0099563) |
0.0 | 0.0 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.0 | 0.0 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.0 | 0.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 0.0 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.0 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.0 | 0.2 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.0 | 0.0 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.0 | 0.0 | GO:0012502 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
0.0 | 0.1 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.0 | 0.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.0 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.0 | 0.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.2 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.1 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.3 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.0 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.0 | 0.3 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.0 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.0 | 0.0 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.1 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.0 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.0 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.0 | 0.0 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.1 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.0 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.0 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0051167 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
0.0 | 0.0 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.1 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.0 | 0.0 | GO:0021730 | aggressive behavior(GO:0002118) trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
0.0 | 0.5 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.0 | 0.0 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.0 | GO:0051494 | negative regulation of cytoskeleton organization(GO:0051494) |
0.0 | 0.0 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.0 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 2.4 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.0 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.0 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.1 | GO:0010885 | regulation of cholesterol storage(GO:0010885) |
0.0 | 0.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.0 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.0 | 0.1 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.4 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 3.5 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.0 | 0.5 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.0 | 0.0 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 5.1 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.9 | 5.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.9 | 4.3 | GO:0032449 | CBM complex(GO:0032449) |
0.8 | 2.5 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.8 | 8.0 | GO:0000796 | condensin complex(GO:0000796) |
0.7 | 2.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.7 | 2.6 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
0.6 | 0.6 | GO:0000806 | Y chromosome(GO:0000806) |
0.6 | 4.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.6 | 5.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.6 | 2.4 | GO:0097196 | Shu complex(GO:0097196) |
0.6 | 1.7 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.6 | 3.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.5 | 1.6 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.5 | 2.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.5 | 2.1 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
0.5 | 2.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.5 | 1.0 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.5 | 1.0 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.5 | 2.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.5 | 1.4 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
0.5 | 1.9 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.5 | 1.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.5 | 2.3 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
0.5 | 1.8 | GO:0000811 | GINS complex(GO:0000811) |
0.4 | 3.5 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.4 | 1.8 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.4 | 0.4 | GO:0005642 | annulate lamellae(GO:0005642) |
0.4 | 1.3 | GO:0098855 | HCN channel complex(GO:0098855) |
0.4 | 0.4 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.4 | 2.5 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.4 | 6.6 | GO:0045120 | pronucleus(GO:0045120) |
0.4 | 1.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.4 | 1.2 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
0.4 | 2.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.4 | 1.2 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 0.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.4 | 1.5 | GO:0043293 | apoptosome(GO:0043293) |
0.4 | 3.1 | GO:0014802 | terminal cisterna(GO:0014802) |
0.4 | 2.3 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.4 | 1.1 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.4 | 1.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.4 | 0.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 2.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.4 | 4.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 1.1 | GO:0043291 | RAVE complex(GO:0043291) |
0.4 | 0.7 | GO:0051286 | cell tip(GO:0051286) |
0.4 | 1.4 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.4 | 1.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.4 | 1.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 22.7 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 1.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 3.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 3.1 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.3 | 1.4 | GO:0045160 | myosin I complex(GO:0045160) |
0.3 | 2.7 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 1.7 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.3 | 2.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 2.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.3 | 0.3 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.3 | 2.2 | GO:0042825 | TAP complex(GO:0042825) |
0.3 | 0.9 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.3 | 0.9 | GO:1990032 | parallel fiber(GO:1990032) |
0.3 | 0.6 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.3 | 1.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.3 | 0.8 | GO:0016938 | kinesin I complex(GO:0016938) |
0.3 | 2.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 2.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.3 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 0.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 2.2 | GO:0035976 | AP1 complex(GO:0035976) |
0.3 | 3.2 | GO:0005840 | ribosome(GO:0005840) |
0.3 | 0.8 | GO:0097447 | dendritic tree(GO:0097447) |
0.3 | 0.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 2.0 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 0.8 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.3 | 2.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.3 | 0.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 1.0 | GO:0032301 | MutSalpha complex(GO:0032301) |
0.2 | 0.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 2.1 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.2 | 2.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.5 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.2 | 0.2 | GO:1990462 | omegasome(GO:1990462) |
0.2 | 1.1 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.2 | 0.9 | GO:0031905 | early endosome lumen(GO:0031905) |
0.2 | 2.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 0.8 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.2 | 1.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 0.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 1.9 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 0.6 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.2 | 0.8 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.2 | 0.6 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.2 | 1.0 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 1.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 1.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.2 | 1.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 1.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 1.4 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 1.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 1.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.6 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.2 | 1.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 1.3 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.2 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 1.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.8 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
0.2 | 1.5 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 2.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 0.6 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.2 | 0.4 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.2 | 0.6 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.2 | 2.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 2.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 6.5 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.2 | 9.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 0.5 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.2 | 1.4 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 2.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 6.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 5.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 1.8 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.2 | 0.7 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.2 | 2.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.2 | 1.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 0.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 1.0 | GO:0019867 | outer membrane(GO:0019867) |
0.2 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 1.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 0.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 0.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 2.0 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 3.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 6.9 | GO:0099738 | cell cortex region(GO:0099738) |
0.2 | 0.8 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.2 | 0.3 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.2 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 0.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 0.3 | GO:0016528 | sarcoplasm(GO:0016528) |
0.2 | 1.6 | GO:0005903 | brush border(GO:0005903) |
0.2 | 0.9 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 0.5 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 1.1 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 0.8 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 0.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.2 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.4 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.1 | 2.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 1.5 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 1.2 | GO:0044437 | vacuolar part(GO:0044437) |
0.1 | 0.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 1.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.4 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.1 | 0.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.7 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 7.6 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.9 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.9 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 0.4 | GO:0071065 | dense core granule membrane(GO:0032127) alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.1 | 0.6 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.1 | 1.0 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 1.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.3 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 2.6 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.4 | GO:0097453 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
0.1 | 1.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.8 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 7.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.1 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.1 | 0.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 1.0 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.4 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.1 | 0.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 2.5 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 1.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.7 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.1 | 1.4 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.9 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.2 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.1 | 2.9 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 4.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.2 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 1.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.5 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.5 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
0.1 | 0.6 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 1.3 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.9 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.7 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 10.8 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.1 | 0.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 14.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 1.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 1.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 1.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.5 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.9 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 5.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 1.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 1.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 1.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.4 | GO:0031213 | RSF complex(GO:0031213) |
0.1 | 0.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.4 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.1 | 0.1 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 1.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 1.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 2.8 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 2.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.3 | GO:0036025 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.1 | 3.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 1.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 2.8 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 3.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 3.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.8 | GO:0030054 | cell junction(GO:0030054) |
0.1 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 2.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.7 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.2 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.1 | 2.3 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.3 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 8.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 2.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 5.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.1 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.1 | 0.2 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 1.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.3 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 1.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 1.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.4 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.5 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.2 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
0.1 | 1.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.4 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.1 | 0.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 8.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 2.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 1.9 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 1.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 1.6 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.4 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
0.1 | 0.8 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 1.0 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 6.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.3 | GO:0044609 | DBIRD complex(GO:0044609) |
0.1 | 2.9 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.7 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 5.9 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.7 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 12.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.7 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.1 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.1 | 1.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.3 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.1 | 13.5 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 1.8 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 1.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 2.7 | GO:0044432 | endoplasmic reticulum part(GO:0044432) |
0.1 | 0.6 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.1 | 0.6 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 1.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 0.8 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.8 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 5.8 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 5.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 1.0 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 5.2 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 0.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.7 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 1.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.3 | GO:0070985 | TFIIK complex(GO:0070985) |
0.1 | 1.1 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.1 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.1 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.5 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 0.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 0.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.8 | GO:0048500 | signal recognition particle(GO:0048500) |
0.1 | 0.3 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 0.6 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.3 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 0.3 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.3 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.1 | 1.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.3 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.1 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.1 | 1.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.9 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.3 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 1.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.1 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.2 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.1 | 0.5 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 5.3 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.3 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 2.4 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 2.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 2.0 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 3.2 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.2 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.1 | 0.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 6.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.1 | GO:0034455 | t-UTP complex(GO:0034455) |
0.1 | 0.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 2.4 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.2 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 0.1 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.5 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.1 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.1 | 0.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.3 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.1 | 0.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 0.4 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 6.6 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.2 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
0.1 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 1.8 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.2 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.1 | 5.7 | GO:0016605 | PML body(GO:0016605) |
0.1 | 3.8 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 19.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 1.9 | GO:0018995 | host(GO:0018995) host cell(GO:0043657) |
0.0 | 0.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.0 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.0 | 3.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 2.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 1.2 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.1 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.0 | 0.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 12.9 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.0 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.4 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 4.5 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 1.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.7 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.3 | GO:0044754 | autolysosome(GO:0044754) |
0.0 | 3.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.5 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.2 | GO:0032280 | symmetric synapse(GO:0032280) |
0.0 | 0.1 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.0 | 1.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.9 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 2.0 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 0.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 5.4 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.2 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.0 | 23.0 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 5.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 4.6 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 2.1 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 3.7 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.0 | 0.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.5 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.1 | GO:0071751 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.0 | 1.2 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 2.0 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.0 | 0.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 1.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 2.7 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.0 | 63.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.0 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.0 | 1.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.4 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 3.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.5 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 24.7 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.4 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.9 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.3 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.0 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.0 | 0.4 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 5.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.5 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 4.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 8.9 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 1.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.6 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.2 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.3 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.7 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.1 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.1 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 3.4 | GO:0098857 | membrane microdomain(GO:0098857) |
0.0 | 0.1 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.1 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 1.0 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.1 | GO:0005767 | secondary lysosome(GO:0005767) |
0.0 | 94.2 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 1.0 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.7 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 1.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.1 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.0 | GO:0005713 | recombination nodule(GO:0005713) |
0.0 | 0.0 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.0 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 10.2 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.2 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.0 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 1.4 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.0 | 0.1 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.0 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.0 | GO:0048179 | activin receptor complex(GO:0048179) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.4 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
1.7 | 8.3 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
1.5 | 7.6 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.5 | 4.5 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
1.5 | 5.9 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.3 | 3.8 | GO:0004797 | thymidine kinase activity(GO:0004797) |
1.2 | 3.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
1.2 | 1.2 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
1.1 | 3.3 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
1.0 | 3.9 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
1.0 | 4.9 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
1.0 | 2.9 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
1.0 | 2.9 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.9 | 3.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.9 | 3.4 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.9 | 2.6 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.8 | 0.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.8 | 3.3 | GO:0052836 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.8 | 2.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.8 | 2.4 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.8 | 0.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.8 | 2.4 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.8 | 2.3 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.7 | 3.0 | GO:0004802 | transketolase activity(GO:0004802) |
0.7 | 2.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.7 | 3.5 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.7 | 2.7 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.7 | 2.0 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.6 | 5.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.6 | 3.8 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.6 | 5.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.6 | 3.6 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.6 | 3.6 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.6 | 3.5 | GO:0042806 | fucose binding(GO:0042806) |
0.6 | 1.8 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.6 | 5.2 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.6 | 2.9 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.6 | 1.7 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
0.6 | 3.9 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.6 | 2.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.5 | 2.1 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.5 | 2.6 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.5 | 1.6 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.5 | 2.6 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.5 | 2.6 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.5 | 2.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.5 | 1.5 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.5 | 2.0 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.5 | 7.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.5 | 3.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.5 | 1.5 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.5 | 0.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.5 | 1.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.5 | 4.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.5 | 2.3 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.5 | 2.3 | GO:0032810 | sterol response element binding(GO:0032810) |
0.5 | 1.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.5 | 3.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.5 | 2.3 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
0.4 | 2.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.4 | 0.9 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.4 | 2.7 | GO:0043515 | kinetochore binding(GO:0043515) |
0.4 | 3.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 3.1 | GO:0046979 | TAP2 binding(GO:0046979) |
0.4 | 2.6 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.4 | 1.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.4 | 1.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 1.7 | GO:0004803 | transposase activity(GO:0004803) |
0.4 | 2.1 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.4 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 4.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 1.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.4 | 4.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.4 | 1.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.4 | 3.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.4 | 1.6 | GO:0008483 | transaminase activity(GO:0008483) |
0.4 | 1.2 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.4 | 2.7 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.4 | 0.8 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 2.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 3.5 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.4 | 1.9 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.4 | 1.5 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.4 | 1.2 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.4 | 1.1 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.4 | 1.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.4 | 5.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.4 | 3.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 1.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.4 | 1.1 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.4 | 1.4 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.4 | 8.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.4 | 0.4 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.4 | 0.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.4 | 6.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 1.8 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.3 | 1.4 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.3 | 1.0 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
0.3 | 1.0 | GO:0097258 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.3 | 1.7 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.3 | 1.0 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
0.3 | 1.0 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.3 | 1.4 | GO:0004104 | acetylcholinesterase activity(GO:0003990) cholinesterase activity(GO:0004104) |
0.3 | 0.7 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.3 | 1.4 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.3 | 1.0 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
0.3 | 1.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 5.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 2.7 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.3 | 1.3 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.3 | 1.3 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.3 | 1.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.3 | 1.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.3 | 1.0 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.3 | 0.3 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.3 | 1.3 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.3 | 1.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.3 | 4.4 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.3 | 1.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 0.9 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.3 | 1.6 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.3 | 0.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 1.8 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.3 | 11.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 3.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 1.2 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
0.3 | 0.9 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 0.9 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.3 | 1.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.3 | 1.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 2.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.3 | 1.8 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.3 | 0.9 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.3 | 1.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.3 | 2.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 1.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 0.9 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.3 | 0.9 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.3 | 5.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.3 | 8.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 2.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.3 | 4.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.3 | 2.0 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.3 | 1.1 | GO:0008431 | vitamin E binding(GO:0008431) |
0.3 | 1.1 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.3 | 2.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 0.8 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
0.3 | 0.8 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.3 | 0.8 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
0.3 | 1.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.3 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.3 | 0.8 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.3 | 1.1 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
0.3 | 0.8 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.3 | 0.8 | GO:0061598 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
0.3 | 0.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 5.9 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 0.8 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.3 | 1.3 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.3 | 4.0 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.3 | 0.5 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.3 | 0.3 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.3 | 1.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.3 | 2.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 0.8 | GO:0036317 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
0.3 | 0.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 0.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.3 | 0.8 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.3 | 1.3 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 1.5 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.3 | 1.5 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.3 | 0.8 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.3 | 0.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.3 | 1.3 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 0.7 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.2 | 0.2 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.2 | 1.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.2 | 1.7 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 1.5 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.2 | 1.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 1.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 0.7 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.2 | 1.0 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.2 | 1.0 | GO:0032143 | single thymine insertion binding(GO:0032143) |
0.2 | 1.0 | GO:0030395 | lactose binding(GO:0030395) |
0.2 | 2.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 0.7 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.2 | 1.4 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.2 | 1.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 5.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 0.9 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.2 | 0.9 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.2 | 0.7 | GO:0015117 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) succinate transmembrane transporter activity(GO:0015141) |
0.2 | 1.2 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.2 | 1.9 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 0.7 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.2 | 0.9 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 0.7 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.2 | 0.9 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.2 | 0.5 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.2 | 1.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 0.7 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 1.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 2.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.2 | 0.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 1.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.2 | 0.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 4.0 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.2 | 0.2 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.2 | 0.7 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.2 | 0.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 0.9 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 2.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 2.6 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 5.9 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.2 | 2.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 0.9 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.2 | 1.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 1.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 3.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 1.0 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.2 | 1.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 0.4 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 0.6 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.2 | 4.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.9 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.6 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.2 | 1.8 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.2 | 3.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 1.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 0.2 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
0.2 | 0.6 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 0.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 0.6 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
0.2 | 0.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 1.8 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 0.6 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.2 | 2.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 0.8 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 2.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 1.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 3.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 1.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 1.0 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 1.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 0.6 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.2 | 0.9 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.2 | 1.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 3.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 0.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 0.6 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 0.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 1.1 | GO:0008948 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
0.2 | 1.8 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 0.4 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.2 | 1.3 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.2 | 0.5 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.2 | 1.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.9 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.5 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.2 | 2.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 1.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 0.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 0.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 3.9 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.2 | 0.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.2 | 1.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 0.5 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.2 | 0.7 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.2 | 0.9 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.9 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.2 | 0.5 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.2 | 0.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.2 | 0.8 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.2 | 2.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 0.7 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.2 | 0.8 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 3.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.2 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
0.2 | 6.6 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 1.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 1.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 0.5 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
0.2 | 5.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 1.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.6 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.2 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.5 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.2 | 0.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 0.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 5.4 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.2 | 1.7 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.2 | 0.3 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.2 | 1.1 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 1.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 2.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 1.1 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 0.5 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
0.2 | 1.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 0.6 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.2 | 0.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 0.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 1.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.9 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 2.1 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 1.4 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.2 | 1.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 0.8 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.2 | 2.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.2 | 1.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 1.7 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.1 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.1 | 1.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.3 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
0.1 | 0.9 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 1.5 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.1 | 1.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.4 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.1 | 2.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.3 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.9 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.1 | 0.6 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.1 | 0.6 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.1 | 4.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 1.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 1.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.4 | GO:0070361 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
0.1 | 0.3 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.1 | 0.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.6 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.1 | 0.4 | GO:0090541 | MIT domain binding(GO:0090541) |
0.1 | 0.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 1.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 1.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 1.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 1.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 1.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 6.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.6 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.1 | 0.6 | GO:0004335 | galactokinase activity(GO:0004335) |
0.1 | 7.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.4 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 1.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.4 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 0.5 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.1 | 0.1 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.1 | 0.5 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 1.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 1.0 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 1.2 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.1 | 1.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.7 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.8 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.4 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.1 | 0.4 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.1 | 1.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 2.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.4 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.1 | 4.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.4 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
0.1 | 0.4 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 2.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.5 | GO:0047708 | biotinidase activity(GO:0047708) |
0.1 | 0.5 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 1.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 1.7 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.8 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 1.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.5 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.1 | 1.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.7 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.1 | 1.0 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 3.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.4 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
0.1 | 5.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 3.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.1 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) transcription factor activity, core RNA polymerase III binding(GO:0000995) |
0.1 | 0.2 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
0.1 | 0.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 0.9 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.1 | 0.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 3.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 1.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.5 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.1 | 0.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.5 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 2.9 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.1 | 2.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.6 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 1.0 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.1 | 3.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.5 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.1 | 0.7 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 1.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 2.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.2 | GO:0046977 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
0.1 | 4.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.5 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.1 | 0.8 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 1.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.1 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 2.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 9.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.3 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.1 | 1.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.7 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 1.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.8 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.1 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.8 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 2.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.3 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.1 | 0.8 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.4 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 1.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 1.1 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 1.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.4 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.5 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 1.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.7 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.1 | 0.3 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 0.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 2.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.4 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.1 | 0.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.7 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.1 | 1.0 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 1.7 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 1.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.6 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 0.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.6 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 1.0 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 6.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.8 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 1.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.9 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 1.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.2 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
0.1 | 0.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.7 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.6 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.1 | 0.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 0.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 2.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.8 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 2.0 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 2.0 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.9 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 2.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.8 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 3.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.4 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.1 | 0.3 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 4.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 9.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 1.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 2.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 2.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 2.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.3 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.1 | 0.5 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 1.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.3 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 0.6 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 1.8 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 1.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.4 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.1 | 0.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.3 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 1.5 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 4.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.7 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 1.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 4.5 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 0.8 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.7 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.1 | 0.9 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 1.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.2 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 4.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 1.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.4 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 0.2 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.1 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 1.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 1.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.2 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.1 | 0.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.2 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.1 | 0.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 2.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 1.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.2 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.1 | 1.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.4 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 2.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.5 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.1 | 1.4 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 0.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.2 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.1 | 2.0 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.2 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.1 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.2 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 2.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.1 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.1 | 0.2 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
0.1 | 0.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.9 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.1 | 1.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 2.9 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 5.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.4 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.4 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.6 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.1 | 2.2 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.1 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 0.2 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.1 | 0.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 1.0 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.9 | GO:0004620 | phospholipase activity(GO:0004620) |
0.1 | 0.4 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.2 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
0.1 | 0.1 | GO:0003909 | DNA ligase activity(GO:0003909) |
0.1 | 0.2 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.1 | 0.1 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
0.1 | 0.1 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 41.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.1 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 0.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 2.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 10.2 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.5 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.2 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 2.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.2 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.1 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 1.1 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.8 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 1.0 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 1.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 1.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.7 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.1 | 2.1 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.2 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
0.1 | 0.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.4 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.2 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.1 | 0.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 3.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 1.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.2 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.1 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.6 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.1 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 0.2 | GO:0070984 | SET domain binding(GO:0070984) |
0.1 | 3.7 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 16.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.6 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.2 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
0.1 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.8 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.2 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 1.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.1 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
0.1 | 1.4 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.5 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.3 | GO:0052841 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.1 | 0.4 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 3.0 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 2.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.4 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.1 | 0.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 0.1 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.1 | 1.0 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 4.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.9 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.4 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.0 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
0.0 | 2.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.1 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.0 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.7 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 2.2 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 2.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.0 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 1.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 1.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.3 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.1 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.0 | 1.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.1 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.0 | 0.1 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.0 | 0.0 | GO:0080122 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.0 | 0.2 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.0 | 2.1 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.3 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 1.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.0 | 2.8 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 1.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.2 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.1 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.0 | 0.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.5 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 2.8 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.1 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 1.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.9 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.2 | GO:0033989 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.0 | 0.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.3 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.2 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.4 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.0 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.2 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.5 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 2.0 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.4 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 1.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 2.1 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 10.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 1.0 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.0 | 0.0 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.6 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 0.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.1 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.0 | 0.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.3 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 1.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 1.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.1 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
0.0 | 0.0 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 1.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.6 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 0.5 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 1.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.4 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 1.0 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 0.1 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.0 | 0.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.1 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
0.0 | 0.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.0 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 2.4 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.4 | GO:0032451 | demethylase activity(GO:0032451) |
0.0 | 0.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.0 | 0.2 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 1.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.0 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.0 | 0.0 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
0.0 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.4 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.2 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.6 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 1.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.1 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.1 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 1.1 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.1 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.0 | 0.1 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.0 | 0.8 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.0 | 0.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.3 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.0 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.0 | 0.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 1.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.0 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.0 | 0.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.1 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 3.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.0 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.0 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.0 | 0.1 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.0 | 0.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.0 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.0 | 0.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.2 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.9 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.0 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.0 | 0.2 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.0 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.0 | 0.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 7.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 1.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 1.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 0.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 1.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 14.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 3.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 2.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 16.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 15.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 1.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 10.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 4.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 11.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 3.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 2.5 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 1.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 4.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 7.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 1.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 2.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 3.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 2.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 1.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 2.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 7.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 2.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 4.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 7.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 8.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 8.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 4.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 2.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 4.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 2.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 2.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 2.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 11.4 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 4.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 3.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 0.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 2.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 3.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 2.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 2.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 1.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 5.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 2.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 1.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 2.7 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 3.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 3.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.7 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 2.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 5.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 1.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 1.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 2.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 1.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.9 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 1.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 1.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 1.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 2.0 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.4 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 3.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.3 | PID FOXO PATHWAY | FoxO family signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.6 | 16.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.5 | 5.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 11.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 1.3 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.4 | 7.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.4 | 13.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.4 | 11.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.4 | 2.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 4.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.3 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.3 | 6.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 11.4 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.3 | 10.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 1.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 1.0 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.3 | 3.0 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.3 | 3.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 6.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 7.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 9.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 5.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 4.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 29.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 3.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 7.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 3.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 4.6 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.2 | 6.6 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 5.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 3.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 0.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 7.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 1.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 3.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 4.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 5.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 0.6 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.2 | 0.4 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.2 | 2.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 6.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 3.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 2.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 3.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 5.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 3.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 0.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 2.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 9.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 5.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 3.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 3.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 2.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 1.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.2 | 0.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 4.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 4.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 2.9 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 2.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 7.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 5.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 3.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 2.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 2.0 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 1.7 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 2.0 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 3.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 3.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.2 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.1 | 2.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 2.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 3.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 2.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 5.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 3.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 2.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 3.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 3.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 2.5 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 2.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 2.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 7.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 4.0 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 2.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 2.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 3.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 1.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.6 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 3.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.6 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.7 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 2.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.6 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 1.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 5.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 5.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 1.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 3.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.4 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 1.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 0.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 2.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 5.4 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 1.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 2.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.1 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.1 | 1.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 4.8 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 0.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 1.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 2.6 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 3.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.8 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.9 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 2.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 3.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.5 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 0.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 2.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.4 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.1 | 0.3 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.1 | 0.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 1.0 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.7 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 2.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 5.5 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 2.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.7 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 1.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 10.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 1.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.5 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.7 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 5.9 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.0 | 0.0 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.0 | 2.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 1.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 1.0 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 3.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.8 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 2.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 1.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 1.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 2.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.5 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.3 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.0 | 0.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 2.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.3 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.0 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 1.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |